Today, Ann Lindberg, Director-General of the Swedish Medical Products Agency (MPA), and Raimund Bruhin, Executive Director of Swissmedic, signed a memorandum of understanding (MoU). The agreement creates a formal framework for closer cooperation on regulatory issues associated with medicinal products and medical devices.
Swissmedic and Swedish partner authority agree on closer collaboration in therapeutic products field
Swissmedic and the Swedish Medical Products Agency (MPA) sign agreement on information exchange
Media release, 19.05.2025
The signing of the memorandum underscores both authorities' shared commitment to efficient, science-based therapeutic products regulation and to the promotion of public health by international cooperation. Through the MoU, the Swedish Medical Products Agency and Swissmedic are expanding information sharing and laying the foundations for greater cooperation on multilateral initiatives.
Using the agreement as a basis, it will be possible to promote reciprocal understanding of regulatory framework conditions, requirements and processes through the structured exchange of information and documents. Furthermore, cooperation between the two authorities in multilateral bodies will be strengthened.
The new agreement is part of a long-term strategy to broaden cooperation with international regulatory networks and partner authorities abroad. Cooperation with the MPA is a further important step in this networking strategy.
Address for enquiries
Swissmedic
Media Unit
+41 58 462 02 76